tradingkey.logo

MannKind To Acquire scPharmaceuticals

ReutersAug 25, 2025 11:33 AM

- MannKind Corp MNKD.O:

  • MANNKIND TO ACQUIRE SCPHARMACEUTICALS, ACCELERATING REVENUE GROWTH AND EMERGING AS A PATIENT-CENTRIC LEADER IN CARDIOMETABOLIC AND LUNG DISEASES

  • MANNKIND CORP - DEAL FOR UPFRONT CASH PAYMENT OF $5.35 PER SHARE PLUS CVR

  • MANNKIND CORP - TOTAL EQUITY VALUE $303 MILLION, DEAL VALUE UP TO $360 MILLION

  • MANNKIND CORP - CO AND BLACKSTONE AMEND FINANCING AGREEMENT FOR $175 MILLION

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI